Search research articles
Contact Us
Filters
Showing results (191-200 of 196) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 196 results.
Annals of Internal Medicine
|
September 1, 1980
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma
J U Gutterman, G R Blumenschein, R Alexanian, et al.
Bone Marrow Transplantation
|
July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
A Shimoni, T L Smith, A Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue
S Giralt, D Weber, M Colome, et al.
British Journal of Haematology
|
October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath, B Barlogie, J Berenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1990
Interferons in the treatment of multiple myeloma
D E Bergsagel, P von Wussow, R Alexanian, et al.
Leukemia
|
July 21, 2006
International uniform response criteria for multiple myeloma
B G M Durie, J-L Harousseau, J S Miguel, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 196) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 196 results.
Annals of Internal Medicine
|
September 1, 1980
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma
J U Gutterman, G R Blumenschein, R Alexanian, et al.
Bone Marrow Transplantation
|
July 31, 2001
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma
A Shimoni, T L Smith, A Aleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue
S Giralt, D Weber, M Colome, et al.
British Journal of Haematology
|
October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma
S Jagannath, B Barlogie, J Berenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1990
Interferons in the treatment of multiple myeloma
D E Bergsagel, P von Wussow, R Alexanian, et al.
Leukemia
|
July 21, 2006
International uniform response criteria for multiple myeloma
B G M Durie, J-L Harousseau, J S Miguel, et al.
Page
of 20